SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-003530
Filing Date
2018-04-30
Accepted
2018-04-30 16:18:11
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20180331x10q.htm 10-Q 1723273
2 EX-31.1 qure-20180331ex311fa3e21.htm EX-31.1 18168
3 EX-31.2 qure-20180331ex31292ddef.htm EX-31.2 18070
4 EX-32.1 qure-20180331ex3210b7784.htm EX-32.1 11131
  Complete submission text file 0001558370-18-003530.txt   6791655

Data Files

Seq Description Document Type Size
5 EX-101.INS qure-20180331.xml EX-101.INS 1443666
6 EX-101.SCH qure-20180331.xsd EX-101.SCH 56654
7 EX-101.CAL qure-20180331_cal.xml EX-101.CAL 47816
8 EX-101.DEF qure-20180331_def.xml EX-101.DEF 232901
9 EX-101.LAB qure-20180331_lab.xml EX-101.LAB 496244
10 EX-101.PRE qure-20180331_pre.xml EX-101.PRE 370769
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 18790013
SIC: 2834 Pharmaceutical Preparations